CBDNewsBreaks – Why Koios Beverage Corp. (CSE: KBEV) is “One to Watch”
Koios Beverage (CSE: KBEV) develops and distributes nature-based products such as nootropics, which are supplements that improve cognitive abilities. An article further discussing the company reads: “Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024. … According to media reports, there is believed…